Uric Acid Level and Prevalence of Atrial Fibrillation in a Japanese General Population of 285,882.
暂无分享,去创建一个
S. Yoshifuku | M. Miyata | M. Ohishi | N. Oketani | T. Kubozono | S. Kawasoe | S. Ojima | H. Miyahara | S. Maenohara
[1] Á. Alonso,et al. Predicting Atrial Fibrillation and Its Complications. , 2016, Circulation journal : official journal of the Japanese Circulation Society.
[2] D. Krummen. Atrial Fibrillation and Heart Failure-- Identification of Patients at Risk. , 2016, Circulation journal : official journal of the Japanese Circulation Society.
[3] Qing He. Hyperuricemia and coronary heart disease , 2016 .
[4] Wen-Chung Yu,et al. Determinants and Prognostic Impact of Hyperuricemia in Hospitalization for Acute Heart Failure. , 2016, Circulation journal : official journal of the Japanese Circulation Society.
[5] R. Mahajan,et al. Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study. , 2015, Journal of the American College of Cardiology.
[6] Gregory Y H Lip,et al. Cardiac Fibrosis in Patients With Atrial Fibrillation: Mechanisms and Clinical Implications. , 2015, Journal of the American College of Cardiology.
[7] Rajiv Mahajan,et al. Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity. , 2015, Journal of the American College of Cardiology.
[8] I. Hisatome,et al. Depletion of Uric Acid Due to SLC22A12 (URAT1) Loss-of-Function Mutation Causes Endothelial Dysfunction in Hypouricemia. , 2015, Circulation journal : official journal of the Japanese Circulation Society.
[9] Jean-Claude Tardif,et al. Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. , 2014, Journal of the American College of Cardiology.
[10] S. Nattel,et al. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. , 2014, Journal of the American College of Cardiology.
[11] T. Chao,et al. The association between hyperuricemia, left atrial size and new-onset atrial fibrillation. , 2013, International journal of cardiology.
[12] J. Balligand,et al. Role of nitric oxide and oxidative stress in a sheep model of persistent atrial fibrillation. , 2013, Europace.
[13] G. Lip,et al. Inflammation in atrial fibrillation. , 2012, Journal of the American College of Cardiology.
[14] Masanori Abe,et al. Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome , 2012, Cardiovascular Diabetology.
[15] A. Folsom,et al. Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study). , 2011, The American journal of cardiology.
[16] C. Lang,et al. Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris. , 2011, Journal of the American College of Cardiology.
[17] Elsayed Z Soliman,et al. Association of Chronic Kidney Disease With Atrial Fibrillation Among Adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study , 2011, Circulation. Arrhythmia and electrophysiology.
[18] Kathleen F. Kerr,et al. European Ancestry as a Risk Factor for Atrial Fibrillation in African Americans , 2010, Circulation.
[19] N. Hastie,et al. A 'complexity' of urate transporters. , 2010, Kidney international.
[20] Hyon K. Choi,et al. Hyperuricemia and coronary heart disease: A systematic review and meta‐analysis , 2010, Arthritis care & research.
[21] Y. Iwasaki,et al. Recruitment of immune cells across atrial endocardium in human atrial fibrillation. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[22] T. Nakayama,et al. Chronic heart failure and the substrate for atrial fibrillation. , 2009, Cardiovascular research.
[23] Yasuhiko Tomino,et al. Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] Elad Anter,et al. Atrial Fibrillation and Heart Failure: Treatment Considerations for a Dual Epidemic , 2009, Circulation.
[25] C. Albert,et al. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. , 2009, Circulation.
[26] D. Levy,et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study , 2009, The Lancet.
[27] R. Terkeltaub,et al. Serum Uric Acid Is Associated with Carotid Plaques: The National Heart, Lung, and Blood Institute Family Heart Study , 2008, The Journal of Rheumatology.
[28] K. Kimura,et al. Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city. , 2008, Circulation journal : official journal of the Japanese Circulation Society.
[29] Stanley Nattel,et al. Atrial Remodeling and Atrial Fibrillation: Mechanisms and Implications , 2008, Circulation. Arrhythmia and electrophysiology.
[30] V. Tikhonoff,et al. Serum uric acid shows a J-shaped trend with coronary mortality in non-insulin-dependent diabetic elderly people. The CArdiovascular STudy in the ELderly (CASTEL) , 2007, Acta Diabetologica.
[31] Roger C Barr,et al. Mechanism of origin of conduction disturbances in aging human atrial bundles: experimental and model study. , 2007, Heart rhythm.
[32] M. Walters,et al. Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease? , 2006, British journal of clinical pharmacology.
[33] H. Endou,et al. Human vascular smooth muscle cells express a urate transporter. , 2006, Journal of the American Society of Nephrology : JASN.
[34] M. Underwood,et al. Diagnosis and management of gout , 2006, BMJ : British Medical Journal.
[35] E. Suresh. Diagnosis and management of gout: a rational approach , 2005, Postgraduate Medical Journal.
[36] M. Rosen,et al. Defective Cardiac Ryanodine Receptor Regulation During Atrial Fibrillation , 2005, Circulation.
[37] James B Seward,et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. , 2002, Journal of the American College of Cardiology.
[38] Rainer Hambrecht,et al. Effects of Xanthine Oxidase Inhibition With Allopurinol on Endothelial Function and Peripheral Blood Flow in Hyperuricemic Patients With Chronic Heart Failure: Results From 2 Placebo-Controlled Studies , 2002, Circulation.
[39] Hirotaka Matsuo,et al. Molecular identification of a renal urate–anion exchanger that regulates blood urate levels , 2002, Nature.
[40] V. Tikhonoff,et al. Predictors of stroke mortality in elderly people from the general population , 2001, European Journal of Epidemiology.
[41] F Santeusanio,et al. Relation Between Serum Uric Acid and Risk of Cardiovascular Disease in Essential Hypertension: The PIUMA Study , 2000, Hypertension.
[42] A. Barnett,et al. Antioxidant status in patients with uncomplicated insulin‐dependent and non‐insulin‐dependent diabetes mellitus , 1997, European journal of clinical investigation.
[43] S. Furukawa,et al. Patients with renal hypouricemia are prone to develop acute renal failure--why? , 1995, Clinical nephrology.
[44] B. Ames,et al. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[45] Jidong Cheng,et al. Underlying Urate-Induced Enhancement of Kv 1 . 5 Channel Expression in HL-1 Atrial Myocytes , 2015 .
[46] E. Boyko,et al. Effects of menopause and hormone replacement therapy on the associations of hyperuricemia with mortality. , 2013, Atherosclerosis.
[47] T. Uejima,et al. Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence. , 2012, Circulation journal : official journal of the Japanese Circulation Society.
[48] A. Meta-analysis. Uric Acid as a Predictor of All-Cause Mortality in Heart Failure: , 2011 .
[49] William A. Richardson,et al. Homozygous SLC2A9 mutations cause severe renal hypouricemia. , 2010, Journal of the American Society of Nephrology : JASN.
[50] D. Kang,et al. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. , 2005, Seminars in nephrology.
[51] M. Nieminen,et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. , 2004, Kidney international.
[52] N. Yoshiike,et al. A 15.5-year follow-up study of stroke in a Japanese provincial city. The Shibata Study. , 1997, Stroke.